JP2003524369A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003524369A5 JP2003524369A5 JP2000509741A JP2000509741A JP2003524369A5 JP 2003524369 A5 JP2003524369 A5 JP 2003524369A5 JP 2000509741 A JP2000509741 A JP 2000509741A JP 2000509741 A JP2000509741 A JP 2000509741A JP 2003524369 A5 JP2003524369 A5 JP 2003524369A5
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US5618597P | 1997-08-19 | 1997-08-19 | |
| US60/056,185 | 1997-08-19 | ||
| PCT/US1997/020023 WO1999009064A1 (en) | 1997-08-19 | 1997-11-04 | Epitope-bearing major histocompatibility complex class ii element/immunoglobulin chimeric molecules |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003524369A JP2003524369A (ja) | 2003-08-19 |
| JP2003524369A5 true JP2003524369A5 (nl) | 2005-12-22 |
Family
ID=22002738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000509741A Pending JP2003524369A (ja) | 1997-08-19 | 1997-11-04 | エピトープを有する主要組織適合複合体クラスｉｉエレメント／免疫グロブリンキメラ分子 |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP1007567A4 (nl) |
| JP (1) | JP2003524369A (nl) |
| AU (1) | AU5428598A (nl) |
| CA (1) | CA2301709C (nl) |
| WO (1) | WO1999009064A1 (nl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6458354B1 (en) | 1996-03-28 | 2002-10-01 | The Johns Hopkins University | Molecular complexes which modify immune responses |
| AU729406B2 (en) | 1996-03-28 | 2001-02-01 | Johns Hopkins University, The | Soluble divalent and multivalent heterodimeric analogs of proteins |
| US6737057B1 (en) | 1997-01-07 | 2004-05-18 | The University Of Tennessee Research Corporation | Compounds, compositions and methods for the endocytic presentation of immunosuppressive factors |
| US6268411B1 (en) | 1997-09-11 | 2001-07-31 | The Johns Hopkins University | Use of multivalent chimeric peptide-loaded, MHC/ig molecules to detect, activate or suppress antigen-specific T cell-dependent immune responses |
| US20030007978A1 (en) * | 1997-09-16 | 2003-01-09 | Burrows Gregory G. | Recombinant MHC molecules useful for manipulation of antigen-specific T-cells |
| BR9908082A (pt) * | 1998-02-19 | 2000-10-31 | Harvard College | Proteìna de fusão do complexo de histocompatibilidade principal classe ii, conjugado dos domìnios de ligação do complexo de histocompatibilidade principal multimérico, processos para detectar células t tendo uma especificidade do complexo definido de mhc / peptìdeo, para conferir a um indivìduo imunidade adotiva a um complexo definido de mhc / peptìdeo, para estimular ou ativar as células t reativas a um complexo definido de mhc / peptìdeo, para seletivamente matar células t reativas a um complexo definido de mhc / peptìdeo, para tolerizar um indivìduo humano a um complexo definido de mhc / peptìdeo, e, ácido nucleico isolado |
| FR2796953B1 (fr) * | 1999-07-29 | 2003-10-10 | Centre Nat Rech Scient | Proteines recombinantes, et complexes moleculaires derives de ces proteines, analogues a des molecules impliquees dans les reponses immunitaires |
| CA2403432A1 (en) * | 2000-03-22 | 2001-09-27 | Corixa Corporation | Immune mediators and related methods |
| US6811785B2 (en) | 2001-05-07 | 2004-11-02 | Mount Sinai School Of Medicine Of New York University | Multivalent MHC class II—peptide chimeras |
| AU2004288157B2 (en) | 2003-09-05 | 2011-03-17 | Oregon Health & Science University | Monomeric recombinant MHC molecules useful for manipulation of antigen-specific T cells |
| CA2595462A1 (en) * | 2005-01-21 | 2006-07-27 | Nalan Utku | Hla fusion molecules and uses thereof |
| KR100754667B1 (ko) * | 2005-04-08 | 2007-09-03 | 한미약품 주식회사 | 비펩타이드성 중합체로 개질된 면역글로불린 Ｆｃ 단편 및이를 포함하는 약제학적 조성물 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5126433A (en) * | 1986-08-21 | 1992-06-30 | The Trustees Of Columbia University In The City Of New York | Soluble forms of the t cell surface protein cd4 |
| US5109123A (en) * | 1988-06-14 | 1992-04-28 | Dana Farber Cancer Institute | Alteration of ability of soluble CD4 fragments to bind HIV |
| US5130297A (en) * | 1988-06-23 | 1992-07-14 | Anergen, Inc. | Conjugates useful in ameliorating autoimmunity MHC-II-peptide |
| WO1993010220A1 (en) * | 1991-11-19 | 1993-05-27 | Anergen, Inc. | Soluble mhc molecules and their uses |
| US5820866A (en) * | 1994-03-04 | 1998-10-13 | National Jewish Center For Immunology And Respiratory Medicine | Product and process for T cell regulation |
-
1997
- 1997-11-04 WO PCT/US1997/020023 patent/WO1999009064A1/en active Application Filing
- 1997-11-04 CA CA2301709A patent/CA2301709C/en not_active Expired - Fee Related
- 1997-11-04 AU AU54285/98A patent/AU5428598A/en not_active Abandoned
- 1997-11-04 EP EP97948162A patent/EP1007567A4/en not_active Withdrawn
- 1997-11-04 JP JP2000509741A patent/JP2003524369A/ja active Pending